Evidence map›Paper›PMID 31091305›Full record

ArticleGlycobiology2019

How altering the modular architecture affects aspects of lectin activity: case study on human galectin-1.

Tanja J Kutzner, Adele Gabba, Forrest G FitzGerald, Nadezhda V Shilova, Gabriel García Caballero, Anna-Kristin Ludwig, Joachim C Manning, Clemens Knospe, Herbert Kaltner, Fred Sinowatz and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring the Galectin Network by Light and Fluorescence Microscopy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Galectin-Glycan Interactions: Guidelines for Monitoring byChemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  10. Article
  11. Article
  12. How galectins have become multifunctional proteins.Histology and histopathology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 5 countries.

Tanja J KutznerInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Adele GabbaSchool of Chemistry, National University of Ireland, Galway, Ireland.
Forrest G FitzGeraldDepartment of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton FL, USA.
Nadezhda V ShilovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Laboratory of Carbohydrates, Russian Academy of Sciences, Moscow, Russia.
Gabriel García CaballeroInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Anna-Kristin LudwigInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Joachim C ManningInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Clemens KnospeInstitute of Anatomy, Histology and Embryology, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Herbert KaltnerInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Fred SinowatzInstitute of Anatomy, Histology and Embryology, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Paul V MurphySchool of Chemistry, National University of Ireland, Galway, Ireland.
Mare CudicDepartment of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton FL, USA.
Nicolai V BovinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Laboratory of Carbohydrates, Russian Academy of Sciences, Moscow, Russia.
Hans-Joachim GabiusInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DEFlorida Atlantic University · USOllscoil na Gaillimhe – University of Galway · IEAuckland University of Technology · NZInstitute of Bioorganic Chemistry · RU

Funding

Novel synthetic tools for mucin glycobiologyR21CA178754 · NCI · FLORIDA ATLANTIC UNIVERSITY · PI CUDIC, MARE · 2014 to 2015
$391k
NCI NIH HHS R21 CA178754
6 · The paper itself

Abstract

Discoveries on involvement of glycan-protein recognition in many (patho)physiological processes are directing attention to exploring the significance of a fundamental structural aspect of sugar receptors beyond glycan specificity, i.e., occurrence of distinct types of modular architecture. In order to trace clues for defining design-functionality relationships in human lectins, a lectin's structural unit has been used as source material for engineering custom-made variants of the wild-type protein. Their availability facilitates comparative analysis toward the stated aim. With adhesion/growth-regulatory human galectin-1 as example, the strategy of evaluating how changes of its design (here, from the homodimer of non-covalently associated domains to (i) linker-connected di- and tetramers and (ii) a galectin-3-like protein) affect activity is illustrated by using three assay systems of increasing degree of glycan complexity. Whereas calorimetry with two cognate disaccharides and array testing with 647 (glyco)compounds disclosed no major changes, galectin histochemical staining profiles of tissue sections that present natural glycome complexity revealed differences between wild-type and linker-connected homo-oligomers as well as between the galectin-3-like variant and wild-type galectin-3 for cell-type positivity, level of intensity at the same site and susceptibility for inhibition by a bivalent glycocompound. These results underscore the strength of the documented approach. Moreover, they give direction to proceed to (i) extending its application to other members of this lectin family, especially galectin-3 and (ii) then analyzing impact of architectural alterations on cell surface lattice formation and ensuing biosignaling systematically, considering the variants' potential for translational medicine.

Indexed as

Protein Processing, Post-TranslationalAmino SugarsAnimalsBinding SitesEpididymisGalectin 1HumansJejunumLactoseMaleMiceMice, Inbred C57BLProtein BindingProtein MultimerizationAmino SugarsGalectin 1lactosamineLactosecalorimetryglycanhistochemistrylectinsugar code

Identifiers

PMID31091305
PMCPMC6639544
OpenAlexW2945126503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.